# NOVOCART® Inject Plus for Cartilage Defects of the Knee

> **NCT03319797** · PHASE3 · COMPLETED · sponsor: **Tetec AG** · enrollment: 100 (actual)

## Conditions studied

- Cartilage Defects of the Knee

## Interventions

- **DRUG:** NOVOCART® Inject plus

## Key facts

- **NCT ID:** NCT03319797
- **Lead sponsor:** Tetec AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-10
- **Primary completion:** 2021-02-22
- **Final completion:** 2024-02-22
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03319797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03319797, "NOVOCART® Inject Plus for Cartilage Defects of the Knee". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03319797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*